Please login to the form below
product launch
This page shows the latest product launch news and features for those working in and with pharma, biotech and healthcare.
Novartis’ CAR-T Kymriah gets green light in England
The company been struggling with production issue for the CAR-T since its US launch last year, specifically variability in product specifications that in some cases have led to manufacturing failures.
Latest news
-
Novartis and Gilead's rival CAR-Ts approved in Europe, but supply capacity in question
It’s been struggling with production issue for the CAR-T since its US launch, specifically variability in product specifications that in some cases have led to manufacturing failures. ... The US biotech says it intends to authorise more than 20 centres
-
FDA clears Kyowa Kirin’s skin lymphoma therapy Poteligeo
The company says it plans to launch the product in the US in the fourth quarter.
-
China’s BeiGene raises $903m from Hong Kong IPO
for registration filings, and for the launch and commercialization of its core product candidates.”.
-
US approval for first ever cannabis-based medicine
The company will have to wait a little longer before it can launch the product, however, because its active ingredient, CBD, needs to be rescheduled under US law. ... Once this recategorisation is completed within the next 90 days, GW Pharma will launch
-
EMA approves GSK’s triple COPD therapy
The EU regulator cleared Trelegy (fluticasone furoate/umeclidinium/vilanterol) - considered to be the most important new product in the company’s ailing respiratory franchise - as a maintenance treatment in adults with ... GSK said in a statement that
More from news
Approximately 1 fully matching, plus 222 partially matching documents found.
Latest Intelligence
-
The handover: Pfizer reshapes itself for a new era
One potential major product launch for 2019 will be novel pain drug tanezumab. ... Our pricing philosophy is to price to the value of the product and price inside a competitive marketplace.
-
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Alnylam and its extraordinary ‘gene silencing’technology is making its debut in Europe with the launch of Onpattro. ... Going it alone. That means a lot is riding on the early success of Onpattro in the US and Europe, and the company has chosen to
-
KAM 2.0
We recently worked on a programme with a global top 15 pharmaceutical company with a vast product portfolio and an imminent, crucial product launch. ... With the relationship and goodwill established, and clear tangible outcomes after the initial meeting,
-
Bluebird Bio: on the cusp of a gene therapy revolution
The firm currently has a market capitalisation value of $8.9bn, even before its first product launch. ... can be measured by increasing vector copy number (VCN) in the drug product.
-
Effective sales performance
To take two extremes:. 1. New products are evaluated first by an individual trying a product. ... In short it is of no value to pursue laggard practices when you launch a new product, your targets should match the promotional focus at that stage of the
More from intelligence
Approximately 0 fully matching, plus 31 partially matching documents found.
Latest appointments
-
Mereo BioPharma appoints head of patient access and commercial planning
Hughes-Wilson brings in-depth market access and product launch expertise as well as a proven ability to develop and lead commercial planning efforts globally. ... In this role, Hughes-Wilson was responsible for Sobi’s commercialisation approach and
-
Alacrita appoints Anna Casse as MD
Life science consulting firm Alacrita has appointed Anna Casse as its new managing director - a role that will see her assume responsibility for Alacrita Europe and help build its European Launch ... I am looking forward to driving further growth in the
-
Hanover Health bolsters PR leadership team
Davies moves to Hanover Health from Tonic Life Communications where he was a senior account director specialising in oncology and neurology product communications, having first joined as an account director in ... 2011. She brings experience in pre- and
-
Dr Andrew Webber joins Life Healthcare Communications
In his new in-house role, Dr Webber will be responsible for overseeing the global launch of a new product within the agency's service portfolio.
-
Former Boehringer diabetes marketing VP joins Gelesis
Dr Pass brings over 20 years of commercial expertise in the diabetes and metabolics areas among others to Gelesis, and takes on responsibility for all business development and product commercialisation, including ... Yishai Zohar, chief executive officer
More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest from PMHub
-
Cholesterol Medicine Market Poised for Steady Growth in the Future
Rising prevalence of cardiovascular diseases and new product launch are expected to drive the global cholesterol medicine market. ... Segment by Product Type. HMG-CoA Reductase Inhibitors (also called Statins). Bile Acid Sequestrants.
-
Worldwide Analysis on Occlusion Balloon Catheter Market Strategies and Forecasts, 2017-2027
New innovative technologies and increasing product launch for balloon catheters has upsurge the growth of occlusion balloon catheter market.
-
Why Infectious Disease Diagnostics Market Will Witness a Staggering Growth During 2026
These companies are majorly focusing on getting approval for the commercialiation of their novel product launch.
-
New ICMJE Guidelines and their Impact on Biotech
Because of this focus, they simply don’ t have the infrastructure in place that we typically associate with implementing a medical communications plan to support a future product launch. ... crucial to securing the funding needed to initiate the
-
Biotech: it's a people business
By developing a team of people who specialise and focus on the product, a company can nurture it along – often a small, novel or complex drug needs that in the beginning.
More from PMHub
Approximately 5 fully matching, plus 11 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Great salary and benefits
-
Senior Medical Writer
-
Competitive Salary
- Senior Systematic Review Analyst - Oxford
-
Negotiable
-
Consumer Health Account Director
-
Circa £60, 000 Gym and More
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
Senior Account Manager
-
Negotiable
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
-
Associate Director
-
£75, 000-90, 000
-
Medical Writers
-
Competitive Salary and Benefits
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
-
New Business Director - PR
-
Competitive Salary and benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Account Director
-
£48, 000 - £60, 000
- Director, Market Access / HEOR - North-West
-
Negotiable
Subscribe to our email news alerts
Latest intelligence
- World Diabetes Day: Interaction and impact of diabetes on mental health
- For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
- Nudge-nudge, think-think
- Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Quick links
Infographics
